Humanities
Skip to main content Skip to main navigation menu Skip to site footer
  • Register
  • Login
  • Menu
  • Home
  • Current
  • Archives
  • Announcements
  • About
    • About the Journal
    • Submissions
    • Editorial Team
    • Privacy Statement
    • Contact
  • Register
  • Login

Journal of Education, Health and Sport

Guillain-Barre Syndrome linked to SARS-CoV-2 infection – meta-analysis and literature review
  • Home
  • /
  • Guillain-Barre Syndrome linked to SARS-CoV-2 infection – meta-analysis and literature review
  1. Home /
  2. Archives /
  3. Vol. 25 No. 1 (2023) /
  4. Articles

Guillain-Barre Syndrome linked to SARS-CoV-2 infection – meta-analysis and literature review

Authors

  • Nikola Siekierko Szpital Praski pw. Przemienienia Pańskiego https://orcid.org/0000-0002-1113-7112
  • Maja Żołnierek Samodzielny Publiczny Specjalistyczny Szpital Zachodni im. św. Jana Pawła II https://orcid.org/0000-0002-4860-2508
  • Wiktoria Kotusiewicz Wojskowy Instytut Medyczny- Państwowy Instytut Badawczy https://orcid.org/0000-0003-4033-0648
  • Mateusz Lewandowski UNIVERSITY CLINICAL CENTER OF WARSAW MEDICAL UNIVERSITY https://orcid.org/0000-0002-4968-1770
  • Grzegorz Bienia Military Institute of Medicine-National Research Institute https://orcid.org/0000-0001-9036-5510
  • Zuzanna Lubczyńska Szpital Grochowski im. dr med. Rafała Masztaka https://orcid.org/0000-0002-4860-2508
  • Yevheniia Popravko Szpital Praski pw. Przemienienia Pańskiego https://orcid.org/0000-0002-1164-1802
  • Jakub Świętochowski Uniwersyteckie Centrum Kliniczne w Gdańsku https://orcid.org/0000-0003-3848-6520

DOI:

https://doi.org/10.12775/JEHS.2023.25.01.004

Keywords

AIDP, AMSAN, COVID-19, GBS, SARS-CoV-2

Abstract

Background

The novel coronavirus disease-2019 (COVID-19), which is caused by Severe Acute Respiratory Distress Syndrome coronavirus 2 (SARS-CoV2), was originally detected in Wuhan, China in December 2019. In this meta-analysis and literature review, we compared and summarized the clinical presentation, cerebrospinal fluid (CSF) and electromyography (EMG) findings and outcomes in SARS-CoV-2 patients with Guillain-Barre Syndrome (GBS) and its variants.

Methods

We conducted a literature review in February 2023 searching for terms “Guillain-Barre Syndrome and COVID-19", “SARS neurology”, “COVID-19 complications”. We used PubMed and Google Scholar databases inquiring case reports or series of cases published between April 1, 2020, and September 14, 2023.

Results

Of the 52 GBS cases 61,5% (n=32) were male and 39,5% (n=20) were female. The mean age was 57 years old. A total of 75% (n=33) patients presented acute inflammatory demyelinating polyneuropathy (AIDP) variant, 6,8% (n=3) presented acute motor axonal neuropathy (AMAN) variant, 15,9% (n=7) presented acute motor-sensory axonal neuropathy (AMSAN) variant. A total of 85,7% (n=42) of patients were diagnosed with albuminocytological dissociation. During the hospitalization, a total of 30,8% (n=16) required mechanical ventilation. A total of 61,5% (n=32) of patients were treated with a 5-day regimen of intravenous immunoglobulin (IVIG) in dose 0.4 g/kg/day. There were 46,1% (n=24) complete recoveries from GBS, 32,7% (n=17) partial recoveries and 9,6% (n=5) of patients did not respond to treatment. A total of 11,5% (n=6) of patients died.

Conclusion

It is crucial to follow patients with COVID-19 and GBS over time to estimate properly the efficacy of treatment and evaluate the real percentage of recovery and complications.

References

WHO coronavirus (COVID-19) dashboard. WHO Coronavirus (COVID-19) Dashboard With Vaccination Data. Accessed January 26, 2023. https://covid19.who.int/

Taubenberger JK, Morens DM. 1918 Influenza: the Mother of All Pandemics. Emerging Infectious Diseases. 2006;12(1). doi:10.3201/eid1201.050979

Peeri NC, Shrestha N, Rahman MS, et al. The SARS, MERS and novel coronavirus (COVID-19) epidemics, the newest and biggest global health threats: what lessons have we learned? International Journal of Epidemiology. 2020;49(3):717-726. doi:10.1093/ije/dyaa033

Wu Y, Xu X, Chen Z, et al. Nervous system involvement after infection with COVID-19 and other coronaviruses. Brain, Behavior, and Immunity. 2020;87. doi:10.1016/j.bbi.2020.03.031

Li Y, Bai W, Hashikawa T. The neuroinvasive potential of SARS‐CoV2 may play a role in the respiratory failure of COVID‐19 patients. Journal of Medical Virology. 2020;92(6). doi:10.1002/jmv.25728

Baig AM, Khaleeq A, Ali U, Syeda H. Evidence of the COVID-19 Virus Targeting the CNS: Tissue Distribution, Host–Virus Interaction, and Proposed Neurotropic Mechanisms. ACS Chemical Neuroscience. 2020;11(7). doi:10.1021/acschemneuro.0c00122

Berger JR. COVID-19 and the nervous system. Journal of Neurovirology. 2020;26(2). doi:10.1007/s13365-020-00840-5

Teixeira-Vaz A, Rocha JA, Reis DA e, et al. Critical COVID-19 and neurological dysfunction - a direct comparative analysis between SARS-CoV-2 and other infectious pathogens. Revista Brasileira de Terapia Intensiva. 2022;34(3). doi:10.5935/0103-507X.20220229-en

Ellul MA, Benjamin L, Singh B, et al. Neurological associations of COVID-19. The Lancet Neurology. 2020;19(9). doi:10.1016/S1474-4422(20)30221-0

Chams N, Chams S, Badran R, et al. COVID-19: A Multidisciplinary Review. Frontiers in Public Health. 2020;8. doi:10.3389/fpubh.2020.00383

Zhou F, Yu T, Du R, et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet (London, England). 2003;395(10229). doi:10.1016/S0140-6736(20)30566-3

Ottaviani D, Boso F, Tranquillini E, et al. Early Guillain-Barré syndrome in coronavirus disease 2019 (COVID-19): a case report from an Italian COVID-hospital. Neurological Sciences. 2020;41(6). doi:10.1007/s10072-020-04449-8

Shang P, Feng J, Wu W, Zhang HL. Intensive Care and Treatment of Severe Guillain–Barré Syndrome. Frontiers in Pharmacology. 2021;12. doi:10.3389/fphar.2021.608130

Willison HJ, Jacobs BC, van Doorn PA. Guillain-Barré syndrome. The Lancet. 2016;388(10045):717-727. doi:10.1016/S0140-6736(16)00339-1

Agosti E, Giorgianni A, D’Amore F, Vinacci G, Balbi S, Locatelli D. Is Guillain-Barrè syndrome triggered by SARS-CoV-2? Case report and literature review. Neurological Sciences. 2021;42(2). doi:10.1007/s10072-020-04553-9

Noon A, Malhi JK, Wong CK. Atypical Guillain-Barré Syndrome Presenting After COVID-19 Infection. Cureus. 2022;14(9). doi:10.7759/cureus.29521

Ilyas U, Umar Z, Bhangal R, Shah D, Fayman B. Guillain-Barré Syndrome: A Sequela of the Original COVID-19 Infection or Vaccination. Cureus. 2022;14(8). doi:10.7759/cureus.28044

Ahmad T, Hamdan S, Saadeh I. Guillain–Barré Syndrome Associated with COVID-19: Two Cases from a Public Hospital in Damascus, Syria. Case Reports in Medicine. 2022;2022. doi:10.1155/2022/9722736

Miyajan KF, Alyamani NA, Zafer DO, Tawakul AA. Guillain-Barré Syndrome in an Elderly Patient as a Complication of COVID-19 Infection. Cureus. 2021;13(10). doi:10.7759/cureus.19154

Al-Zadjali MM, Shibli EA, Maskari MA, Gujjar AR, Asmi AA. Post-COVID-19 Guillain-Barré Syndrome: A case report from Oman. Sultan Qaboos University Medical Journal. 2022;22(3). doi:10.18295/squmj.6.2021.090

Khaja M, Gomez GPR, Santana Y, et al. A 44-Year-Old Hispanic Man with Loss of Taste and Bilateral Facial Weakness Diagnosed with Guillain-Barré Syndrome and Bell’s Palsy Associated with SARS-CoV-2 Infection Treated with Intravenous Immunoglobulin. The American Journal of Case Reports. 2020;21. doi:10.12659/AJCR.927956

Sharma S, Adhikari A, Ghimire N, Mainali G, Yadav SK, Rajkarnikar R. Guillain-Barré Syndrome associated with SARS-CoV-2 infection in Nepal: A case report. Annals of Medicine and Surgery. 2022;80. doi:10.1016/j.amsu.2022.104214

Ivan AP, Odajiu I, Popescu BO, Davidescu EI. COVID-19 Associated Guillain–Barré Syndrome: A Report of Nine New Cases and a Review of the Literature. Medicina. 2022;58(8). doi:10.3390/medicina58080977

Devarakonda AK, Stumpe TR, Saucier AN, Riley T. Neurological Consequences of COVID-19: A Curious Case of Delayed Onset Guillain-Barre. Cureus. 2022;14(5). doi:10.7759/cureus.25325

Cea G, Romero C, Aguilar S, et al. Guillain-Barré syndrome in patients with SARS-CoV-2 infection. Report of three cases. Revista médica de Chile. 149(12):1812-1816. doi:10.4067/s0034-98872021001201812

Rane RP, Jain A, Hussain KM, Naik S, Shahab A. A Rare Case of Guillain-Barré Syndrome Associated With SARS-CoV-2 Infection Requiring Mechanical Ventilation. Cureus. 2022;14(6). doi:10.7759/cureus.25810

Živković V, Gačić EM, Djukić D, Nikolić S. Guillain–Barré syndrome as a fatal complication of SARS-CoV-2 infection – An autopsy case. Legal Medicine (Tokyo, Japan). 2022;57. doi:10.1016/j.legalmed.2022.102074

Carpenter K, Iqbal A, Singh R, et al. COVID-19 Infection and Guillain-Barre Syndrome: A Case Series. Cureus. 2022;14(2). doi:10.7759/cureus.21998

Nigatu D, Tigabu T, Awraris M, Yohannes A, Kebede D. Guillain-Barré Syndrome Associated with SARS CoV-2 Infection: Case Report. Ethiopian Journal of Health Sciences. 2022;32(1). doi:10.4314/ejhs.v32i1.21

Kaeley N, Kabi A, Pillai A, Shankar T, S alva AMS. Post-COVID-19 Guillain-Barré Syndrome: A Case Report With Literature Review. Cureus. 2022;14(1). doi:10.7759/cureus.21246

Toy E, Kart K. Intensive care management in guillain barré syndrome accompanying prolonged Covid-19–A case report. Nigerian Journal of Clinical Practice. 2022;25(2). doi:10.4103/njcp.njcp_85_21

Zhao H, Shen D, Zhou H, Liu J, Chen S. Guillain-Barré syndrome associated with SARS-CoV-2 infection: causality or coincidence? The Lancet Neurology. 2020;19(5). doi:10.1016/S1474-4422(20)30109-5

Sedaghat Z, Karimi N. Guillain Barre syndrome associated with COVID-19 infection: A case report. Journal of Clinical Neuroscience. 2020;76. doi:10.1016/j.jocn.2020.04.062

Ottaviani D, Boso F, Tranquillini E, et al. Early Guillain-Barré syndrome in coronavirus disease 2019 (COVID-19): a case report from an Italian COVID-hospital. Neurological Sciences. 2020;41(6). doi:10.1007/s10072-020-04449-8

Alberti P, Beretta S, Piatti M, et al. Guillain-Barré syndrome related to COVID-19 infection. Neurology® Neuroimmunology & Neuroinflammation. 2020;7(4). doi:10.1212/NXI.0000000000000741

Padroni M, Mastrangelo V, Asioli GM, et al. Guillain-Barré syndrome following COVID-19: new infection, old complication? Journal of Neurology. 2020;267(7). doi:10.1007/s00415-020-09849-6

Coen M, Jeanson G, Almeida LAC, et al. Guillain-Barré syndrome as a complication of SARS-CoV-2 infection. Brain, Behavior, and Immunity. 2020;87. doi:10.1016/j.bbi.2020.04.074

Otmani HE, Moutawakil BE, Rafai MA, et al. Covid-19 and Guillain-Barré syndrome: More than a coincidence! Revue Neurologique. 2020;176(6). doi:10.1016/j.neurol.2020.04.007

Scheidl E, Canseco DD, Hadji‐Naumov A, Bereznai B. Guillain‐Barr é syndrome during SARS‐CoV ‐2 pandemic: A case report and review of recent literature. Journal of the Peripheral Nervous System. 2020;25(2):204-207. doi:10.1111/jns.12382

Riva N, Russo T, Falzone YM, et al. Post-infectious Guillain–Barré syndrome related to SARS-CoV-2 infection: a case report. Journal of Neurology. 2020;267(9). doi:10.1007/s00415-020-09907-z

Assini A, Benedetti L, Maio SD, Schirinzi E, Sette MD. New clinical manifestation of COVID-19 related Guillain-Barrè syndrome highly responsive to intravenous immunoglobulins: two Italian cases. Neurological Sciences. 2020;41(7). doi:10.1007/s10072-020-04484-5

Bigaut K, Mallaret M, Baloglu S, et al. Guillain-Barré syndrome related to SARS-CoV-2 infection. Neurology® Neuroimmunology & Neuroinflammation. 2020;7(5). doi:10.1212/NXI.0000000000000785

Chan JL, Ebadi H, Sarna JR. Guillain-Barré Syndrome with Facial Diplegia Related to SARS-CoV-2 Infection. Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques. 2020;47(6):852-854. doi:10.1017/cjn.2020.106

Toscano G, Palmerini F, Ravaglia S, et al. Guillain–Barré Syndrome Associated with SARS-CoV-2. New England Journal of Medicine. 2020;382(26):2574-2576. doi:10.1056/nejmc2009191

Lascano AM, Epiney J ‐b., Coen M, et al. SARS‐CoV‐2 and Guillain–Barré syndrome: AIDP variant with a favourable outcome. European Journal of Neurology. 2020;27(9). doi:10.1111/ene.14368

Berg B van den, Walgaard C, Drenthen J, Fokke C, Jacobs BC, van Doorn PA. Guillain-Barré syndrome: pathogenesis, diagnosis, treatment and prognosis - PubMed. Nature reviews Neurology. 2014;10(8). doi:10.1038/nrneurol.2014.121

Caress JB, Castoro RJ, Simmons Z, et al. COVID‐19–associated Guillain‐Barré syndrome: The early pandemic experience. Muscle & Nerve. 2020;62(4). doi:10.1002/mus.27024

Jacobs BC, van Doorn PA, Tio-Gillen AP, et al. Campylobacter jejuni infections and anti‐GM1 antibodies in guillain‐barré syndrome. Annals of Neurology. 40(2):181-187. doi:10.1002/ana.410400209

Dimachkie MM, Barohn RJ. Guillain-Barré Syndrome and Variants. Neurologic clinics. 2013;31(2). doi:10.1016/j.ncl.2013.01.005

Hughes RA, Swan AV, van Doorn PA. Intravenous immunoglobulin for Guillain‐Barré syndrome - Hughes, RAC - 2014. Cochrane Database of Systematic Reviews. 2014;(9). doi:10.1002/14651858.CD002063.pub6

Shang P, Feng J, Wu W, Zhang HL. Intensive Care and Treatment of Severe Guillain–Barré Syndrome. Frontiers in Pharmacology. 2021;12. doi:10.3389/fphar.2021.608130

Verboon C, van Doorn PA, Jacobs BC. Treatment dilemmas in Guillain-Barré syndrome. Journal of Neurology, Neurosurgery & Psychiatry. 2017;88(4):346-352. doi:10.1136/jnnp-2016-314862

Chevret S, Hughes RA, Annane D. Plasma exchange for Guillain‐Barré syndrome. The Cochrane Database of Systematic Reviews. 2017;2017(2). doi:10.1002/14651858.CD001798.pub3

Beydoun HA, Beydoun MA, Hossain S, Zonderman AB, Eid SM. Nationwide study of therapeutic plasma exchange vs intravenous immunoglobulin in Guillain‐Barré syndrome. Muscle & Nerve. 61(5):608-615. doi:10.1002/mus.26831

Greene-Chandos, Torbey. Critical Care of Neuromuscular Disorders : CONTINUUM: Lifelong Learning in Neurology. LWW. https://journals.lww.com/continuum/Abstract/2018/12000/Critical_Care_of_Neuromuscular_Disorders.11.aspx

Kleyweg RP, Meché FG van der. Treatment related fluctuations in Guillain-Barré syndrome after high-dose immunoglobulins or plasma-exchange. Journal of Neurology, Neurosurgery, and Psychiatry. 1991;54(11). doi:10.1136/jnnp.54.11.957

El-Bayoumi MA, El-Refaey AM, Abdelkader AM, El-Assmy MM, Alwakeel AA, El-Tahan HM. Comparison of intravenous immunoglobulin and plasma exchange in treatment of mechanically ventilated children with Guillain Barré syndrome: a randomized study. Critical Care. 2011;15(4). doi:10.1186/cc10305

Charra B, Hachimi A, Benslama A, Motaouakkil S. Intravenous immunoglobulin vs plasma exchange in treatment of mechanically ventilated adults with Guillain-Barré syndrome. The Pan African Medical Journal. 2014;18. doi:10.11604/pamj.2014.18.35.2911

Islam B, Islam Z, Rahman S, et al. Small volume plasma exchange for Guillain-Barré syndrome in resource-limited settings: a phase II safety and feasibility study. BMJ Open. 2018;8(8). doi:10.1136/bmjopen-2018-022862

Hahn AF. The Challenge of Respiratory Dysfunction in Guillain-Barré Syndrome. Archives of Neurology. 2001;58(6):871-872. doi:10.1001/archneur.58.6.871

Chakraborty, Kramer, Wijdicks, Rabinstein. Dysautonomia in Guillain–Barré Syndrome: Prevalence, Clinical Spectrum, and Outcomes. Neurocritical Care. 2019;32(1):113-120. doi:10.1007/s12028-019-00781-w

Shang P, Zhu M, Baker M, Feng J, Zhou C, Zhang HL. Mechanical ventilation in Guillain-Barré syndrome - PubMed. Expert review of clinical immunology. 2020;16(11). doi:10.1080/1744666X.2021.1840355

Lawn ND, Fletcher DD, Henderson RD, Wolter TD, Wijdicks EF. Anticipating mechanical ventilation in Guillain-Barré syndrome - PubMed. Archives of neurology. 2001;58(6). doi:10.1001/archneur.58.6.893

Green C, Baker T, Subramaniam A. Predictors of respiratory failure in patients with Guillain-Barré syndrome: a systematic review and meta-analysis - PubMed. The Medical journal of Australia. 2018;208(4). doi:10.5694/mja17.00552

Umer SR, Nisa Q, Kumari M, Abbas S, Mahesar SA, Shahbaz NN. Clinical Features Indicating the Need for Mechanical Ventilation in Patients with Guillain Barre Syndrome. Cureus. 2019;11(8):e5520. doi:10.7759/cureus.5520

Hadden RDM, Cornblath DR, Hughes RAC, et al. Electrophysiological classification of guillain‐barré syndrome: Clinical associations and outcome. Annals of Neurology. 44(5):780-788. doi:10.1002/ana.410440512

Downloads

  • PDF

Published

2023-05-02

How to Cite

1.
SIEKIERKO, Nikola, ŻOŁNIEREK, Maja, KOTUSIEWICZ, Wiktoria, LEWANDOWSKI, Mateusz, BIENIA, Grzegorz, LUBCZYŃSKA, Zuzanna, POPRAVKO, Yevheniia and ŚWIĘTOCHOWSKI, Jakub. Guillain-Barre Syndrome linked to SARS-CoV-2 infection – meta-analysis and literature review. Journal of Education, Health and Sport. Online. 2 May 2023. Vol. 25, no. 1, pp. 40-56. [Accessed 19 May 2025]. DOI 10.12775/JEHS.2023.25.01.004.
  • ISO 690
  • ACM
  • ACS
  • APA
  • ABNT
  • Chicago
  • Harvard
  • IEEE
  • MLA
  • Turabian
  • Vancouver
Download Citation
  • Endnote/Zotero/Mendeley (RIS)
  • BibTeX

Issue

Vol. 25 No. 1 (2023)

Section

Articles

License

Copyright (c) 2023 Nikola Siekierko, Maja Żołnierek, Wiktoria Kotusiewicz, Mateusz Lewandowski, Grzegorz Bienia, Zuzanna Lubczyńska, Yevheniia Popravko, Jakub Świętochowski

Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.

The periodical offers access to content in the Open Access system under the Creative Commons Attribution-NonCommercial-ShareAlike 4.0

Stats

Number of views and downloads: 627
Number of citations: 0

Search

Search

Browse

  • Browse Author Index
  • Issue archive

User

User

Current Issue

  • Atom logo
  • RSS2 logo
  • RSS1 logo

Information

  • For Readers
  • For Authors
  • For Librarians

Newsletter

Subscribe Unsubscribe

Tags

Search using one of provided tags:

AIDP, AMSAN, COVID-19, GBS, SARS-CoV-2
Up

Akademicka Platforma Czasopism

Najlepsze czasopisma naukowe i akademickie w jednym miejscu

apcz.umk.pl

Partners

  • Akademia Ignatianum w Krakowie
  • Akademickie Towarzystwo Andragogiczne
  • Fundacja Copernicus na rzecz Rozwoju Badań Naukowych
  • Instytut Historii im. Tadeusza Manteuffla Polskiej Akademii Nauk
  • Instytut Kultur Śródziemnomorskich i Orientalnych PAN
  • Instytut Tomistyczny
  • Karmelitański Instytut Duchowości w Krakowie
  • Ministerstwo Kultury i Dziedzictwa Narodowego
  • Państwowa Akademia Nauk Stosowanych w Krośnie
  • Państwowa Akademia Nauk Stosowanych we Włocławku
  • Państwowa Wyższa Szkoła Zawodowa im. Stanisława Pigonia w Krośnie
  • Polska Fundacja Przemysłu Kosmicznego
  • Polskie Towarzystwo Ekonomiczne
  • Polskie Towarzystwo Ludoznawcze
  • Towarzystwo Miłośników Torunia
  • Towarzystwo Naukowe w Toruniu
  • Uniwersytet im. Adama Mickiewicza w Poznaniu
  • Uniwersytet Komisji Edukacji Narodowej w Krakowie
  • Uniwersytet Mikołaja Kopernika
  • Uniwersytet w Białymstoku
  • Uniwersytet Warszawski
  • Wojewódzka Biblioteka Publiczna - Książnica Kopernikańska
  • Wyższe Seminarium Duchowne w Pelplinie / Wydawnictwo Diecezjalne „Bernardinum" w Pelplinie

© 2021- Nicolaus Copernicus University Accessibility statement Shop